WUXIDARX
LIVE

Serial Number

98218315

Owner

WUXI XDC SINGAPORE PRIVATE LIMITED

Attorney

Michael T. Smith

First Use Date

Oct 17, 2023

Filing Date

Oct 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

WUXIDARX Trademark

Serial Number: 98218315 • Registration: 7763549

WUXIDARX is a trademark filed by WUXI XDC SINGAPORE PRIVATE LIMITED on October 11, 2023. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

WUXI XDC SINGAPORE PRIVATE LIMITED (3 trademarks)

100 TRAS STREET #16-01
100 AM SINGAPORE 079027 , SG

Entity Type: 24

Trademark Details

Filing Date

October 11, 2023

Registration Date

April 15, 2025

First Use Anywhere

October 17, 2023

First Use in Commerce

October 17, 2023

Published for Opposition

August 20, 2024

Goods & Services

Custom assembling of materials, namely, custom assembling of antibody drug conjugates and intermediates thereof for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of drug conjugates; Customized production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates; Processing and treating of chemical reagents, namely, custom production of reagents for scientific or medical research use; Pharmaceutical processing, namely, processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; Processing of biomedical preparations for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of chemical materials for production of drug conjugates for others

Development of new products for others; pharmaceutical drug development service; Research and development of new products; Biochemical research and development; Custom design and development of chemical reagent antibodies and conjugate antibodies; Research and development in the field of pharmaceutical biomedicine and biotechnology, namely, research of antibodies, namely, conjugated antibodies; Biomedical research services; Development of pharmaceutical preparations and medicines; Research and development of Antibody-drug Conjugates; Research and development of drug conjugates

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 27, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 27, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 24, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 24, 2025 AITU
USE AMENDMENT FILED
Jan 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 17, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 15, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2024 CNRT
ASSIGNED TO EXAMINER
May 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2023 NWOS
NEW APPLICATION ENTERED
Oct 14, 2023 NWAP